通过结合基于抗体的免疫疗法和小分子抑制剂来准急性白血病,进一步迈出了一步

Armin Dozandeh-Jouybari1,2, Erfan Rohaninia3, Sara Faaliat3

  • 1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

PubMed
概括

使用基于抗体的治疗方法和小分子抑制剂的组合疗法在治疗急性白血病方面表现有前途,在临床试验中可能比单一疗法更有效.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K